First-in-Human(FIH)Trialat36Months:37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback